Filter
1089
Filtered Results: 1089
Text search:
and
G.
Breed
Featured
Recommendations
145
New Publications
310
Language
Document type
No document type
617
Guidelines
198
Studies & Reports
149
Manuals
53
Training Material
24
Strategic & Response Plan
21
Fact sheets
16
Situation Updates
4
Infographics
3
Online Courses
2
Brochures
1
App
1
Countries / Regions
India
100
Global
43
Kenya
42
South Africa
35
Ethiopia
27
Nigeria
26
Philippines
23
Sierra Leone
22
Liberia
22
Nepal
18
Rwanda
17
Uganda
17
Bangladesh
14
Ghana
12
Tanzania
12
Myanmar / Burma
12
Malawi
11
Indonesia
11
Syria
10
Africa
9
Congo, Democratic Republic of
9
Zimbabwe
8
Western and Central Europe
8
Latin America and the Carribbean
7
South–East Asia Region
7
Zambia
6
South Sudan
6
Guinea
5
Asia
5
Botswana
5
Lesotho
4
Venezuela
4
Germany
4
West and Central Africa
4
Brazil
4
Namibia
4
Burkina Faso
3
Mozambique
3
Cambodia
3
Madagascar
3
Eswatini/ Swaziland
3
Pakistan
3
Colombia
2
China
2
Chile
2
Senegal
2
Afghanistan
2
Mongolia
2
USA
2
Western Pacific Region
2
Eastern Europe and Central Asia
2
Argentina
2
Papua New Guinea
2
Sudan
2
Yemen
2
Central African Republic
2
Mali
2
Somalia
2
North Macedonia
1
Ukraine
1
Benin
1
Cameroon
1
Fiji
1
Kyrgyzstan
1
Italy
1
Haiti
1
Dominican Republic
1
Guinea-Bissau
1
Middle East and North Africa
1
Paraguay
1
Denmark
1
Mauritius
1
East and Southern Africa
1
Sri Lanka
1
Russia
1
Honduras
1
Iraq
1
Ecuador
1
Solomon Islands
1
Authors & Publishers
Publication Years
Category
Countries
436
Clinical Guidelines
189
Women & Child Health
103
Public Health
64
Capacity Building
43
Key Resources
34
Pharmacy & Technologies
7
Toolboxes
Planetary Health
66
NTDs
51
Rapid Response
47
Ebola
46
Caregiver
44
COVID-19
39
AMR
34
Pharmacy
32
HIV
28
Mental Health
27
TB
26
Refugee
20
NCDs
20
Conflict
19
Zika
16
Global Health Education
15
Natural Hazards
13
Specific Hazards
10
Disability
9
Health Financing Toolbox
5
Polio
3
Cholera
2
Social Ethics
2
The International Pharmaceutical Federation (FIP) is a global federation of national associations of pharmacists and
pharmaceutical scientists. In order to support these associations in their fight against AMR, FIP has prepared this
briefing document. It is an overview of the different activities ...
Development of one or more vaccines for Neisseria gonorrhoeae is an important objective for sexual and reproductive health worldwide, and for the fight against antimicrobial resistance.
WHO preferred product characteristics (PPCs) provide strategic guidance as to WHO’s preferences for new vacci...
These guidelines are based on the 3rd Edition of the WHO Guidelines (Published 2015) World Health Organization’s Guidelines for the treatment of malaria. Additional literature surveys have been undertaken. Factors that were considered in the choice of therapeutic options included effectiveness, sa...
This document focuses on the management of patients affected by gambiense HAT and
constitutes an update to the WHO therapeutic guidance issued in 2013. The main changes in recommendations concern the criteria and methods for deciding the treatment among the new set of therapeutic options and the pa...
Patients with diabetes are at increased risk of developing cardiovascular disease (CVD) with its manifestations of coronary artery disease (CAD), heart failure (HF), atrial fibrillation (AF), and stroke, as well as aortic and peripheral artery diseases. In addition, diabetes is a major risk factor f...
This Training module on malaria elimination has been developed by WHO to support health professionals in planning, managing, monitoring and evaluating malaria elimination programmes.
Supporting exercises: These files are necessary for participants to complete a number of exercises listed in the man...
PNAS | March 4, 2014 | vol. 111 | no. 9
Malaria is an important disease that has a global distribution and significant health burden. The spatial limits of its distribution and seasonal activity are sensitive to climate factors, as well as the local capacity to control the disease. Malaria is also ...
Medicinal plants occupied an important position in the socio-cultural, spiritual and medicinal arena of rural people of India. T
The present report is based on contribution made by members of the task force and many other experts on medicinal plants. We hope the report on implementation will promot...
With this World Health Day, WHO is drawing attention to a group of diseases that are spread by insects and other vectors, the heavy health and economic burdens they impose, and what needs to be done to reduce these burdens. Many of these diseases have been historically confined to distinct geographi...
Working document from an informal consultation of experts. A Protocol for risk assessment at the field level. The purpose of document is to provide guidance on the methodology to be used for assessing, at field level, the yellow fever virus circulation in areas at risk, and is primarily intended fo...
The Global vector control response 2017–2030 (GVCR) provides a new strategy to strengthen vector control worldwide through increased capacity, improved surveillance, better coordination and integrated action across sectors and diseases.
In May 2017, the World Health Assembly adopted resolutio...
In May 2017, the World Health Assembly adopted resolutio...
The aim of this document is to provide interim guidance for interventions to reduce the risk of maternal Zika virus infection and to manage potential complications during pregnancy. This guidance is based on the best available research evidence and covers areas prioritized by an international, multi...
Update 2021; Immunization, Vaccines and Biologicals
This document provides the specifications for major pesticide application equipment used for control of vectors of diseases. The specification guidelines contained herein are intended to assist national authorities and other public health users in selecting equipment of assured quality for applicati...
Antibiotics have been a critical public health tool since the discovery of Penicillin in 1928, saving the lives of millions of people around the world. In developing country like ours, where the burden of treatable disease is very high and access to health facilities and laboratories is difficult, a...
This policy brief aims to provide a review of the current progress on implementing the Burkina Faso national action plan on AMR, identifies critical gaps, and highlights findings to accelerate further progress in the human health sector. The target audience includes all those concerned with implemen...
This policy brief aims to provide a review of the current progress on implementing the Malawi national action plan on AMR, identifies critical gaps, and highlights findings to accelerate further progress in the human health sector. The target audience includes all those concerned with implementing a...
This policy brief aims to provide a review of the current progress on implementing the Kenya national action plan on AMR, identifies critical gaps, and highlights findings to accelerate further progress in the human health sector. The target audience includes all those concerned with implementing ac...
A qualitative assessment of knowledge gaps about female genital schistosomiasis among communities living in Schistosoma haematobium endemic districts of Zanzibar and Northwestern Tanzania.
PloS Neglected Tropical Diseases September 30, 2021 https://doi.org/10.1371/journal.pntd.0009789
Schistosoma...
Female Genital Schistosomiasis (FGS) is a gynaecological disease caused by Schistosoma haematobium, a parasitic worm that is acquired by skin contact with freshwater contaminated by schistosome cerceriae. Communities in which the infection is most endemic have limited access to clean water and healt...
